pathway increased, while AT2 level decreased. Interestingly, PLA2 and COX1/COX2 expressions in AA pathway increased in model group and their expressions were down-regulated by ACEI drug captopril, indicating that AA pathway was activated by up-regulation of RAAS. As important signal-transducing proteins, JAK1/STAT3, NFkb and Akt expressions all increased in model group remarkably. QSYQ treatment could attenuate myocardial fibrosis and this effecacy were further approved by decreasing levels of collagen I, collagen III, MMP2 and MMP9 in QSYQ group. RAAS pathway was inhibited by QSYQ, as indicated by decreased AT1 and increased AT2 expressions. PLA2, COX1 and COX2 expressions were also down-regulated in QSYQ group. In addition, "therapeutic" QSYQ administration seemed to downregulate JAK1/STAT3, NFkb and Akt expressions which maybe play important roles in myocardial fibrosis.
CONCLUSIONS AA pathway in myocardial fibrosis may be mediated by activation of RAAS in HF model rats. QSYQ can exert anti-fibrosis effect by downregulating expressions of RAAS pathway, and subsequently inhibiting proteins in AA pathway. The mechanism of QSYQ cardiac protective efficacy may be through RAAS-JAK1/STAT3, Akt and PLA2-COXs-NFkb pathways. Our study provides new insights into the complicated mechanism of QSYQ in the clinical treatment of HF. OBJECTIVES To explore the safe range of lipopolysaccharide(LPS) density and provide the experimental data for the related research of human coronary artery smooth muscle cells (HCASMC) associated with inflammation, we investigated the effects of different ratios of LPS at different points on the growth of HCASMC cultivated in vitro.
GW26-e1244 Effects of Lipopolysaccharide on the Growth and Proliferation of Human Coronary Artery Smooth Muscle Cells in Vitro

METHODS
The 3-5 generations of HCASMC was respectively seeded onto 96-well plates, then co-incubated with different concentration of LPS (0,0.01,0.1,0.5,1,5,10, and 100mg/ml) at different points (24,48, and 72h). Then cell viability was determined via methylthiazoletetrazolium (MTT) assay. We determined the optimal concentration range and time of LPS for promoting the growth of HCASMC.
RESULTS
The effect of LPS on the growth and proliferation of HCASMC was related with the density and action-time. Beyond certain density, the smaller action-time of LPS (0, 24, 48h) did not inhibit the growth of HCASMC but could increase the growth of HCASMC; The longer action-time of LPS (72h) with high dose (1-100mg/ ml) could obviously inhibit the growth of HCASMC and the inhibitory rate increased with the increase in the concentration of LPS. Besides, with the same density, the longer action-time would decrease the cell viability of HCASMC more obviously.
CONCLUSIONS The low dose of LPS (<1mg/ml) cannot obviously produce cytotoxicity of HCASMC, and 0.01mg/ml LPS with action-time of 24h can maximize the proliferation of HCASMC, which can be used in the experimental study of HCASMC cultured in the inflammation condition.
GW26-e1257
Perivascular adipose tissue-derived adiponectin inhibits collar-induced carotid atherosclerosis by promoting macrophage autophagy CONCLUSIONS Our studies demonstrated that PVAT-secreted APN suppresses plaque formation by inducing macrophage autophagy.
GW26-e1351 Effect of Rosuvastatin on Blood Pressure, Mesenteric Arteries Structure and Vasodilatation Function in Spontaneously Hypertensive Rats
Zhoufei Fang, Liangdi Xie First Affiliated Hospital of Fujian Medical University OBJECTIVES To study the effect of Rosuvastatin (Rsv) on blood pressure, vascular structure and vasodilatation function of 3 rd grade branch mesenteric in spontaneously hypertensive rats (SHRs).
METHODS Thirty-two male SHRs at 12 wks old were randomly divided into 2 groups: Rosuvastatin (SHR-R, n¼16, 10mg$kg -1 $d -1 ) and untreated controls (SHR, n¼16). Age-and weight-matched WKY rats served as control s(WKY, n¼16). The control rats were administrated equivalent distilled water. Systolic blood pressure (SBP) was determined by tail-cuff method before treatment, 4 and 8 wks after treatment. The wall-to-lumen area ratios (W/L), the ratios of wall thickness (WT) to lumen radius (LR) of 3 rd grade branch mesenteric arteries were assessed morphometrically. Endothelium-dependent relaxation (EDdR), endothelium-independent relaxation (EDiR) were measured by PowerLab biological signal analytical system. Serum 25-Hydroxyvitamin D(25(OH)D) was determined by ELISA. rd grade branch mesenteric arteries in Rsvtreated rats were markedly lower than that of untreated SHR after 8wks treatment. WT/LR in Rsv-treated rats was similar to the level as that of WKY( P>0.05 CONCLUSIONS The treatment of Rosuvastatin may mildly lower blood pressure, increase the plasma level of 25(OH)D, attenuate remodeling of 3 rd grade branch mesenteric arteries, and ameliorate vasodilatation function in SHRs. The increase of vasodilatation function was prior to improvement of vascular structure.
GW26-e2113
Polymorphisms in the CELSR2-PSRC1-SORT1 are associated with serum lipid traits, the risk of coronary artery disease and ischemic stroke Yijiang Zhou, Qian Yang, Ruixing Yin Department of Cardiology, Institute of Cardiovascular Diseases, the First Affiliated Hospital, Guangxi Medical University OBJECTIVES Recent genome-wide association studies (GWAS) have identified CELSR2-PSRC1-SORT1 variants on chromosome 1p13.3 associated with CAD and plasma lipoproteins based on populations of European, eastern Asia, southern Asia, Middle-Eastern Asia, and Africa Americans. Some loci were found to affect the risk of CAD and IS. However, there were no data in the southern Chinese populations. Our study was to assess the association of CELSR2-PSRC1-SORT1 
